RXO INC (RXO) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:RXO • US74982T1034

16.9 USD
+0.32 (+1.93%)
At close: Feb 6, 2026
16.93 USD
+0.03 (+0.18%)
After Hours: 2/6/2026, 8:05:08 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

Overall RXO gets a fundamental rating of 3 out of 10. We evaluated RXO against 42 industry peers in the Ground Transportation industry. While RXO seems to be doing ok healthwise, there are quite some concerns on its profitability. RXO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • RXO had negative earnings in the past year.
  • RXO had a positive operating cash flow in the past year.
  • In multiple years RXO reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: RXO reported negative operating cash flow in multiple years.
RXO Yearly Net Income VS EBIT VS OCF VS FCFRXO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M 300M

1.2 Ratios

  • RXO's Return On Assets of -2.47% is on the low side compared to the rest of the industry. RXO is outperformed by 64.29% of its industry peers.
  • RXO has a worse Return On Equity (-5.00%) than 64.29% of its industry peers.
  • The Return On Invested Capital of RXO (0.38%) is worse than 66.67% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for RXO is in line with the industry average of 6.91%.
  • The last Return On Invested Capital (0.38%) for RXO is well below the 3 year average (6.68%), which needs to be investigated, but indicates that RXO had better years and this may not be a problem.
Industry RankSector Rank
ROA -2.47%
ROE -5%
ROIC 0.38%
ROA(3y)-1.25%
ROA(5y)1.16%
ROE(3y)-0.55%
ROE(5y)3.28%
ROIC(3y)6.68%
ROIC(5y)7.55%
RXO Yearly ROA, ROE, ROICRXO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

  • The Operating Margin of RXO (0.19%) is worse than 66.67% of its industry peers.
  • In the last couple of years the Operating Margin of RXO has declined.
  • The Gross Margin of RXO (16.53%) is worse than 71.43% of its industry peers.
  • In the last couple of years the Gross Margin of RXO has remained more or less at the same level.
Industry RankSector Rank
OM 0.19%
PM (TTM) N/A
GM 16.53%
OM growth 3Y-45.97%
OM growth 5Y-25.79%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.37%
GM growth 5Y-0.88%
RXO Yearly Profit, Operating, Gross MarginsRXO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), RXO is destroying value.
  • RXO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
RXO Yearly Shares OutstandingRXO Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M
RXO Yearly Total Debt VS Total AssetsRXO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 2.86 indicates that RXO is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With a decent Altman-Z score value of 2.86, RXO is doing good in the industry, outperforming 61.90% of the companies in the same industry.
  • A Debt/Equity ratio of 0.24 indicates that RXO is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.24, RXO is doing good in the industry, outperforming 61.90% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z 2.86
ROIC/WACC0.04
WACC10.16%
RXO Yearly LT Debt VS Equity VS FCFRXO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

  • RXO has a Current Ratio of 1.32. This is a normal value and indicates that RXO is financially healthy and should not expect problems in meeting its short term obligations.
  • RXO has a Current ratio of 1.32. This is comparable to the rest of the industry: RXO outperforms 59.52% of its industry peers.
  • A Quick Ratio of 1.32 indicates that RXO should not have too much problems paying its short term obligations.
  • The Quick ratio of RXO (1.32) is better than 61.90% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 1.32
RXO Yearly Current Assets VS Current LiabilitesRXO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • RXO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -145.45%.
EPS 1Y (TTM)-145.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-216.67%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-11.88%

3.2 Future

  • The Earnings Per Share is expected to grow by 244.37% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, RXO will show a quite strong growth in Revenue. The Revenue will grow by 9.55% on average per year.
EPS Next Y330.28%
EPS Next 2Y244.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.84%
Revenue Next 2Y4.76%
Revenue Next 3Y15.95%
Revenue Next 5Y9.55%

3.3 Evolution

RXO Yearly Revenue VS EstimatesRXO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B 10B
RXO Yearly EPS VS EstimatesRXO Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 0.5 1

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for RXO. In the last year negative earnings were reported.
  • RXO is valuated quite expensively with a Price/Forward Earnings ratio of 146.78.
  • 64.29% of the companies in the same industry are cheaper than RXO, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of RXO to the average of the S&P500 Index (27.78), we can say RXO is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 146.78
RXO Price Earnings VS Forward Price EarningsRXO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 -100 -200 -300

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, RXO is valued a bit more expensive than the industry average as 64.29% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 23.87
RXO Per share dataRXO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • RXO's earnings are expected to grow with 244.37% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y244.37%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for RXO!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

RXO INC

NYSE:RXO (2/6/2026, 8:05:08 PM)

After market: 16.93 +0.03 (+0.18%)

16.9

+0.32 (+1.93%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryGround Transportation
Earnings (Last)02-06
Earnings (Next)05-05
Inst Owners110.21%
Inst Owner Change-0.74%
Ins Owners0.65%
Ins Owner Change0.23%
Market Cap2.77B
Revenue(TTM)N/A
Net Income(TTM)-79.00M
Analysts66.92
Price Target15.77 (-6.69%)
Short Float %6.03%
Short Ratio4.97
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)14.37%
Min EPS beat(2)-72.3%
Max EPS beat(2)101.04%
EPS beat(4)2
Avg EPS beat(4)-7.18%
Min EPS beat(4)-72.3%
Max EPS beat(4)101.04%
EPS beat(8)6
Avg EPS beat(8)10.08%
EPS beat(12)9
Avg EPS beat(12)46.37%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.1%
Min Revenue beat(2)-2.41%
Max Revenue beat(2)-1.8%
Revenue beat(4)0
Avg Revenue beat(4)-2.52%
Min Revenue beat(4)-5.04%
Max Revenue beat(4)-0.83%
Revenue beat(8)1
Avg Revenue beat(8)-1.44%
Revenue beat(12)2
Avg Revenue beat(12)-2.37%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.36%
PT rev (3m)-7.42%
EPS NQ rev (1m)-43.8%
EPS NQ rev (3m)-160.42%
EPS NY rev (1m)-112.75%
EPS NY rev (3m)-101.24%
Revenue NQ rev (1m)-0.66%
Revenue NQ rev (3m)-3.84%
Revenue NY rev (1m)-0.21%
Revenue NY rev (3m)-1.86%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 146.78
P/S 0.47
P/FCF N/A
P/OCF 74.96
P/B 1.76
P/tB N/A
EV/EBITDA 23.87
EPS(TTM)-0.05
EYN/A
EPS(NY)0.12
Fwd EY0.68%
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)0.23
OCFY1.33%
SpS36.2
BVpS9.63
TBVpS-0.04
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.47%
ROE -5%
ROCE 0.48%
ROIC 0.38%
ROICexc 0.38%
ROICexgc 1.27%
OM 0.19%
PM (TTM) N/A
GM 16.53%
FCFM N/A
ROA(3y)-1.25%
ROA(5y)1.16%
ROE(3y)-0.55%
ROE(5y)3.28%
ROIC(3y)6.68%
ROIC(5y)7.55%
ROICexc(3y)7.11%
ROICexc(5y)7.93%
ROICexgc(3y)19.6%
ROICexgc(5y)21.22%
ROCE(3y)8.45%
ROCE(5y)9.55%
ROICexgc growth 3Y-52.22%
ROICexgc growth 5YN/A
ROICexc growth 3Y-56.75%
ROICexc growth 5YN/A
OM growth 3Y-45.97%
OM growth 5Y-25.79%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.37%
GM growth 5Y-0.88%
F-Score4
Asset Turnover1.86
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Debt/EBITDA 2.93
Cap/Depr 45.45%
Cap/Sales 0.93%
Interest Coverage 0.35
Cash Conversion 28.03%
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 1.32
Altman-Z 2.86
F-Score4
WACC10.16%
ROIC/WACC0.04
Cap/Depr(3y)71.18%
Cap/Depr(5y)64.7%
Cap/Sales(3y)1.27%
Cap/Sales(5y)1.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-145.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-216.67%
EPS Next Y330.28%
EPS Next 2Y244.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-11.88%
Revenue Next Year2.84%
Revenue Next 2Y4.76%
Revenue Next 3Y15.95%
Revenue Next 5Y9.55%
EBIT growth 1Y-71.79%
EBIT growth 3Y-46.51%
EBIT growth 5Y-20.08%
EBIT Next Year161.52%
EBIT Next 3Y73.49%
EBIT Next 5Y56.44%
FCF growth 1Y-121.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-74.66%
OCF growth 3YN/A
OCF growth 5YN/A

RXO INC / RXO FAQ

What is the fundamental rating for RXO stock?

ChartMill assigns a fundamental rating of 3 / 10 to RXO.


What is the valuation status for RXO stock?

ChartMill assigns a valuation rating of 1 / 10 to RXO INC (RXO). This can be considered as Overvalued.


What is the profitability of RXO stock?

RXO INC (RXO) has a profitability rating of 3 / 10.


What is the expected EPS growth for RXO INC (RXO) stock?

The Earnings per Share (EPS) of RXO INC (RXO) is expected to grow by 330.28% in the next year.